Similar articles

• The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.

  Meehan SM, Domer P, Josephson M, Donoghue M, Sadhu A, Ho LT, Aronson AJ, Thistlethwaite JR, Haas M. Meehan SM, et al. Hum Pathol. 2001 Feb;32(2):205-15. doi: 10.1053/hupa.2001.21574. Hum Pathol. 2001. PMID: 11230708
• Proliferation rate of cells in the interstitial infiltrate in acute kidney allograft rejection.

  Olsen S, Hansen HE. Olsen S, et al. Transplant Proc. 1996 Feb;28(1):502-3. Transplant Proc. 1996. PMID: 8644329 No abstract available.
• Immunohistological study of a pediatric patient with plasma cell-rich acute rejection.

  Chikamoto H, Sugawara N, Akioka Y, Shimizu T, Horita S, Honda K, Moriyama T, Koike J, Yamaguchi Y, Hattori M. Chikamoto H, et al. Clin Transplant. 2012 Jul;26 Suppl 24:54-7. doi: 10.1111/j.1399-0012.2012.01638.x. Clin Transplant. 2012. PMID: 22747477
• Use of intragraft gene expression in the diagnosis of kidney allograft rejection.

  Pavlakis M, Strehlau J, Lipman M, Strom TB. Pavlakis M, et al. Transplant Proc. 1996 Aug;28(4):2019-21. Transplant Proc. 1996. PMID: 8769141 Review. No abstract available.
• New insights into therapy with monoclonal antibodies in allograft transplantation.

  Schena FP. Schena FP. Nephrol Dial Transplant. 1997;12 Suppl 1:55-8. Nephrol Dial Transplant. 1997. PMID: 9075230 Review. No abstract available.